These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9511278)

  • 1. [Recommendations for the diagnosis and therapy of hyperlipoproteinemia in childhood and adolescence developed by the Committee of the Czech Society for Atherosclerosis].
    Urbanová Z; Samánek M; Ceska R; Cífková R; Poledne R; Rosolová H; Soska V; Simon J; Vaverková H; Widimský J; Widimský J; Zadák Z
    Cas Lek Cesk; 1998 Feb; 137(3):89-92. PubMed ID: 9511278
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recommendations for diagnosis and therapy of hyperlipoproteinemias in adulthood prepared by the Czech Atherosclerosis Society].
    Ceska R; Cífková R; Poledne R; Rosolová H; Soska V; Simon J; Sobra J; Vaverková H; Widimský J; Widimský J; Zadák Z
    Cas Lek Cesk; 1997 Apr; 136(8):257-61. PubMed ID: 9264871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recommendations for the diagnosis and therapy of hyperlipoproteinemias in adults prepared by the Czech Atherosclerosis Society].
    Ceska T; Cílková R; Poledne R; Rosolová H; Soska V; Simon J; Sobra J; Vaverková H; Widimský J; Widimský J; Zadák Z
    Vnitr Lek; 1997 Sep; 43(9):621-5. PubMed ID: 9750474
    [No Abstract]   [Full Text] [Related]  

  • 4. [What was not included in the recommendations for the diagnosis and therapy of hyperlipoproteinemia in childhood].
    Samánek M; Urbanová Z; Ceska R
    Cas Lek Cesk; 1998 May; 137(10):303-8. PubMed ID: 9650361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperlipoproteinemia in children].
    Urbanová Z
    Vnitr Lek; 2016; 62(11):882-886. PubMed ID: 28128574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperlipoproteinemia. Epidemiology, physiopathology, diagnosis, principles of dietary and drug treatment].
    Brun JM; Pacaud A
    Rev Prat; 1992 Jun; 42(11):1412-8. PubMed ID: 1529258
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperlipoproteinemia. Epidemiology, etiology, physiopathology, diagnosis, diet and drug therapy].
    Moulin P; Berthezène F
    Rev Prat; 1995 Jun; 45(12):1546-54. PubMed ID: 7660012
    [No Abstract]   [Full Text] [Related]  

  • 8. Intertriginous xanthomas: a marker of homozygous type IIa hyperlipoproteinemia.
    Manchanda Y; Sharma VK
    Int J Dermatol; 2004 Sep; 43(9):676-7. PubMed ID: 15357750
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dyslipidemias and atherosclerosis. Treatment strategy].
    Pometta D
    Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1173-6. PubMed ID: 3775162
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary hyperlipoproteinemias. Clinical, biological and physiopathological aspects].
    Bakir R; Chanu B; Rouffy J
    Sem Hop; 1983 Nov; 59(41):2861-71. PubMed ID: 6316552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of hyperlipoproteinemia to atherosclerosis.
    Scheig R
    Conn Med; 1983 May; 47(5):259-63. PubMed ID: 6861495
    [No Abstract]   [Full Text] [Related]  

  • 12. Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(2):82-5. PubMed ID: 24335037
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical aspects of hyperlipoproteinemia (author's transl)].
    Kaffarnik H; Schneider J
    Ther Umsch; 1980 Nov; 37(11):973-9. PubMed ID: 7455962
    [No Abstract]   [Full Text] [Related]  

  • 14. The hyperlipoproteinemias.
    Whayne TF
    J Fam Pract; 1980 Nov; 11(5):789-99. PubMed ID: 7430980
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperlipoproteinemias. Epidemiology, etiology, physiopathology, diagnosis, treatment].
    Chadarevian R; Cohen-Presberg P; Bruckert E; Turpin G
    Rev Prat; 1998 Jun; 48(12):1353-9. PubMed ID: 9781197
    [No Abstract]   [Full Text] [Related]  

  • 16. [Early recognition of hyperlipoproteinemias and intervention].
    Schwandt P
    Bibl Nutr Dieta; 1992; (50):19-27. PubMed ID: 1288481
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hyperlipoproteinemia mass screening in a pediatric patient group].
    László A; Joó I; Turi S
    Kinderarztl Prax; 1982 Oct; 50(10):506-17. PubMed ID: 7154521
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
    Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperlipoproteinemias. Epidemiology, etiology, physiopathology, diagnosis, treatment].
    Moulin P
    Rev Prat; 2001 Jun; 51(12):1379-87. PubMed ID: 11503513
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of hyperlipoproteinemia--clinical aspects.
    Schlierf G; Nikolaus T; Oster P; Kruse W
    Prog Clin Biol Res; 1988; 255():197-203. PubMed ID: 3340638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.